Stock Markets June 26, 2026 09:14 AM

Quantum Corp. Shares Slide After Northland Lowers Rating, Keeps $13 Target

Analyst says current share price already reflects long-term free cash flow assumptions, limiting upside

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
QMCO

Quantum Corp. (NASDAQ:QMCO) experienced an intraday pullback after Northland cut its rating to Market Perform from Outperform while leaving its $13.00 price target unchanged. The downgrade follows a notable run-up in the stock from roughly $7 a share at the time of Northland's November 2025 upgrade to about $13 today. Northland analyst Nehal Chokshi said the firm's long-term free cash flow margin expectations are now embedded in the stock, reducing prospective upside.

Quantum Corp. Shares Slide After Northland Lowers Rating, Keeps $13 Target
QMCO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Quantum Corp. stock fell after Northland downgraded the rating from Outperform to Market Perform while keeping a $13.00 price target.
  • Northland notes the stock has risen from about $7 per share at the November 2025 upgrade to around $13 now, and says the current valuation already embeds a 10% long-term free cash flow margin.
  • The analysts $13 target is based on an expectation of a 10% operating margin and an approximate 40% gross margin; the downgrade reflects limited upside from current levels.

Quantum Corp. (NASDAQ:QMCO) shares dropped sharply on Friday after Northland reduced its recommendation on the stock to Market Perform from Outperform, while maintaining a $13.00 price target. The move came amid a sizable gain in the stock since Northland's prior upgrade in November 2025.

Shares had risen from approximately $7 per share at the time of Northland's upgrade in November 2025 to roughly $13 currently, a surge the analyst flagged as central to the revised rating. Trading data showed the shares closed at $12.93 on Thursday, just below the firms unchanged $13 valuation anchor.

Northland commentary

"Downgrading to MP from OP as valuation now embeds our 10% long-term FCF margin, in our view. We are reiterating our $13 PT while downgrading our rating to MP as we note shares have appreciated from $7/share since upgrading in November 2025 to ~$13/share currently. Our unchanged $13 PT has consistently been based on our expectation that QMCO will achieve a 10% OM, which we believe is reasonable given the target ~40% GM."

In explaining the adjustment, Northlands analyst Nehal Chokshi said the stock's present valuation appears to incorporate the firm's long-term free cash flow margin assumptions, which reduces the scope for further price appreciation from current levels. Although the $13 price target remains in place, the shift from an Outperform to a Market Perform rating signals a more cautious posture driven by the recent rally.

Market and investor implications

The downgrade and accompanying sell-off reflect re-evaluation of upside potential, given the analyst's view that key long-term margin metrics are already reflected in the share price. The change in rating may influence short-term market sentiment among equity investors tracking the company.

What remains clear from Northlands note

  • The firm's $13 price target is unchanged and continues to be predicated on an expectation of a 10% operating margin and about a 40% gross margin.
  • The downgrade to Market Perform follows significant appreciation in the stock since the November 2025 upgrade, reducing runway for additional gains under Northlands framework.

Investors and market observers will likely monitor whether trading settles around the $13 level or if the stock diverges further from the analysts valuation assumptions in the coming sessions.

Risks

  • Valuation risk: Northland believes current share price already reflects long-term free cash flow margin expectations, which implies limited upside for equity holders and potential for price volatility in equities.
  • Market sentiment risk: The downgrade from Outperform to Market Perform could weigh on investor sentiment, affecting trading volatility in Quantums stock and related equity market participants.
  • Repricing risk: If market participants reassess the company's ability to meet the margin assumptions underpinning the $13 target, the stock could reprice; this risk affects investors exposed to the companys equity.

More from Stock Markets

Opus Genetics Shares Gain After Firm Is Slotted Into Three Russell Indexes Jun 26, 2026 Tel Aviv Stocks Slip as TA 35 Hits One-Month Low; Tech, Communication and Insurance Lead Declines Jun 26, 2026 Oslo benchmarks retreat as energy and transport names weigh on market Jun 26, 2026 Anixa Biosciences Shares Slip After Company Presents Phase 1 Breast Vaccine and Ovarian CAR-T Data Jun 26, 2026 Hemab Therapeutics Shares Rise After Multiple ISTH Data Presentations Announced Jun 26, 2026